Clinical trial · Observational
China Pituitary Disease Registry (CAPASITY)
China Pituitary Disease Registry Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Epidemiologic studies have revealed a tremendous increase in the prevalence of pituitary disease and related mortality worldwide. In order to meet all the challenges in the treatment of pituitary disease in China, CAPASITY was founded in 2020. The objective of CAPASITY is to launch a pituitary disease management model based on the Internet health information platform. It allows the application and evaluation of pituitary disease treatment strategies at multiple centers. The proprietary electronic medical database will help the dynamic big-data analysis in epidemiology of pituitary disease, diagnosis, and treatment.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pituitary Disease | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- percentage of functional pituitary adenoma
- timeFrame
- through study completion, an average of 1 year
- description
- percentage of PRLoma, GHoma, ACTHoma, and etc
- measure
- remission and recurrence rate of pituitary surgery
- timeFrame
- through study completion, an average of 1 year
- description
- treatment outcome of pituitary adenoma. Results will be dichotomized as remission, persistence or recurrence.
Secondary outcomes (11)
- measure
- concentration of GH
- timeFrame
- through study completion, an average of 1 year
- description
- changes in GH
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 14 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Age ≥ 18 years old and ≤ 75 years * Patients diagnosed with pituitary adenomas, and other pituitary diseases * Pituitary adenomas resected by transsphenoidal surgery were identified by histological diagnoses. * Gender: males and females * Provide written informed consent * Satisfactory compliance Exclusion Criteria: * Patients with significantly reduced life expectancy (less than 2 years) * With Drug abuse * With AIDS or syphilis or infectious diseases such as viral tuberculosis in active phase at enrollment
References
Publications (0)
Data not yet available